Novel oral anticoagulants and reversal agents: Considerations for clinical development-Reference-Cited by-同舟云学术

Novel oral anticoagulants and reversal agents: Considerations for clinical development

Published:2015-06 Issue:6 Volume:169 Page:751-757
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Sarich Troy C.,Seltzer Jonathan H.,Berkowitz Scott D.,Costin' James,Curnutte John T.,Gibson C. Michael,Hoffman Maureane,Kaminskas Edvardas,Krucoff Mitchell W.,Levy Jerrold H.,Mintz Paul D.,Reilly Paul A.,Sager Philip T.,Singer Daniel E.,Stockbridge Norman,Weitz Jeffrey I.,Kowey Peter R.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference15 articles.

1. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation;Gage;JAMA,2001

2. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials;Arch Intern Med,1994

3. Temporal trends in ischemic stroke and anticoagulation therapy among Medicare patients with atrial fibrillation: a 15-year perspective (1992-2007);Shroff;JAMA Intern Med,2013

4. ROCKET AF Investigators. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation;Patel;N Engl J Med,2011

5. RE-LY Steering Committee and Investigators. Dabigatran versus warfarin in patients with atrial fibrillation;Connolly;N Engl J Med,2009

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-Vitamin K Antagonist Oral Anticoagulants in Differentiated Approach to the Use in Cardiological Practice: Literature Review;Ukrainian Journal of Cardiovascular Surgery;2023-09-28

2. Evaluation and management of oral anticoagulant bleeding: quid didicimus? (what have we learned?);Journal of Thrombosis and Haemostasis;2023-03

3. Therapeutic considerations for prevention and treatment of thrombotic events in COVID-19;Thrombosis Update;2023-03

4. Heparin and Its Derivatives: Challenges and Advances in Therapeutic Biomolecules;International Journal of Molecular Sciences;2021-09-29

5. Edoxaban (LIXIANA®) in the treatment of venous thromboembolism;Future Cardiology;2021-08